GHRH analogue comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Last reviewed on 2026-08-01. Where a claim depends on a specific study, the study is described rather than over-claimed.
The drug affinity complex is a maleimidopropionic acid group attached to a lysine side chain. It reacts with the free thiol of cysteine-34 on circulating albumin, forming a covalent bond. This conjugation keeps the peptide in the bloodstream and shields it from rapid renal filtration and proteolysis. Reported circulation half-lives for the albumin-bound form fall in the range of roughly six to nine days in early human studies.
Binding to GHRH receptors on pituitary somatotroph cells triggers cyclic AMP signaling and stimulates growth hormone synthesis and release. Because the peptide acts upstream of the pituitary, effects are mediated through endogenous growth hormone rather than direct receptor activation in peripheral tissues. Increases in insulin-like growth factor 1 are generally described as a downstream consequence. Most published human exposure data come from small early-stage studies, and the clinical significance of the pharmacokinetic profile remains incompletely characterized.
CJC-1295 is a synthetic analogue of growth hormone-releasing hormone, built on the 29-amino-acid GHRH(1-29) fragment. Four substitutions distinguish it from the natural sequence: D-alanine at position 2, glutamine at position 8, alanine at position 15, and leucine at position 27. These changes reduce enzymatic cleavage and extend the peptide's persistence in circulation. The compound is discussed in two forms, one carrying a drug affinity complex and one without it.
Reports on this compound commonly follow serum growth hormone and insulin-like growth factor 1 across defined time windows. Protocols differ in sampling frequency, assay platform, and participant characteristics, which makes direct comparison between publications difficult. Some work focuses on pulsatile release patterns instead of average concentrations. Whether repeated exposure alters endogenous hormone rhythms over long periods remains an open question, and the formal literature is thinner than the volume of informal commentary implies.
Once in circulation, the peptide binds the growth hormone-releasing hormone receptor displayed on pituitary somatotroph cells. Receptor activation couples to Gs proteins, elevates intracellular cyclic AMP, and drives protein kinase A signaling inside the cell. That cascade increases discharge of growth hormone into the bloodstream. The analog therefore operates through a receptor pathway that already exists for the body's own releasing hormone, rather than through an engineered artificial target.
Clearance profiles diverge sharply between the two versions. The albumin-binding molecule stays in plasma for several days, whereas the unmodified analog is largely gone within about half an hour in reported work. Cleavage by dipeptidyl peptidase IV is a major contributor to the short life of the unmodified sequence. These gaps mean the two versions cannot be substituted for each other in study design or in reading results side by side.
| Property | Value | Notes |
|---|---|---|
| Physical form | Lyophilized white powder | Supplied as a freeze-dried solid for research use |
| Molecular weight | Approximately 3,647 Da (DAC form) | Lower for the variant lacking the albumin-binding moiety |
| Solubility | Soluble in water and aqueous buffer | Typically dissolved in sterile or bacteriostatic water |
| Typical storage temperature | −20 °C or below | Dry powder, desiccated and protected from light |
| Common analytical method | Reversed-phase HPLC with mass spectrometry | Used for purity estimation and identity confirmation |
Heseltine spent nine weeks in the ranks as a Guardsman before being sent for three months of officer training at Mons Officer Cadet School, Aldershot, alongside men from other regiments. He was a capable cadet, reaching the rank of Junior Under-Officer and graduating with an A-Grade, but he was not awarded the Sword of Honour or promoted to the rank of Senior Under-Officer, as it was felt his age had given him an unfair advantage over younger cadets. Throughout his training he had been troubled by an old ankle sprain, but he declined the offer of a medical discharge. He was commissioned as a second lieutenant on 11 June 1959. Heseltine was granted leave to contest the general election in October that year; according to Ian Josephs this had been his plan from the start. Afterward he applied on business grounds for exemption from return to the Army, in part because of difficulties caused by an employee's embezzlement, and partly including the need to sort out his late father's affairs, and was exempted from his remaining sixteen months of service. During the 1980s his habit of wearing a Guards regimental tie, sometimes incorrectly knotted with a red stripe on the neck, was the subject of much acerbic comment from military figures and from older MPs with distinguished war records. Crick estimated that he must have worn the tie on more days than he actually served in the Guards.
=== Use in research === Baculovirus-insect cell expression is a technique used to produce large quantities of a desired protein. It takes advantage of the ability of Baculovirus to insert genes into its target cell and induce protein expression this gene. Numerous insect cells have been developed into cell lines, such as fruit flies, mosquitoes, and silkworms. The tissue of the cabbage looper has also been used to develop a cell line. It is particularly useful for its fast growth rate and less reliance upon insect haemolymph in the medium. The cabbage looper cell line has also been engineered to grow in serum-free media. Although animal serum helps insect cell growth, it is very expensive and can hinder subsequent experimental procedures. As a result, the development of the cell line to grow independently of serum means that the cell line could be used to produce viruses and proteins in a more affordable, efficient, and productive manner.
44 (9): 1829. doi:10.1016/0009-2509(89)85125-5. M. König (2008). Herstellung und Charakterisierung nanoporöser Monolithe auf Basis poröser Gläser mit optimierter geometrischer Form zur Anwendung in der Sensortechnik. Diplomarbeit, Halle.
== Function == Class I MHC molecules bind peptides generated mainly from the degradation of cytosolic proteins by the proteasome. The MHC I: peptide complex is then inserted via the endoplasmic reticulum into the external plasma membrane of the cell. The epitope peptide is bound on extracellular parts of the class I MHC molecule. Thus, the function of the class I MHC is to display intracellular proteins to cytotoxic T cells (CTLs). However, class I MHC can also present peptides generated from exogenous proteins, in a process known as cross-presentation. A normal cell will display peptides from normal cellular protein turnover on its class I MHC, and CTLs will not be activated in response to them due to central and peripheral tolerance mechanisms. When a cell expresses foreign proteins, such as after viral infection, a fraction of the class I MHC will display these peptides on the cell surface. Consequently, CTLs specific for the MHC:peptide complex will recognize and kill presenting cells. Alternatively, class I MHC itself can serve as an inhibitory ligand for natural killer cells (NKs). Reduction in the normal levels of surface class I MHC, a mechanism employed by some viruses and certain tumors to evade CTL responses, activates NK cell killing.
==== Appointment ==== In October 1982 Secretary of State for Defence John Nott announced that he was stepping down from Parliament at the next election. As defence was expected to be a major issue at the election, it made sense to appoint his successor as soon as possible, and Heseltine's name was widely touted. Over the winter of 1982–1983 there were frequent rumours that military top brass were lobbying against his appointment, strongly denied to the press by Willie Whitelaw (Home Secretary and de facto Deputy Prime Minister) and Chief of Defence Staff Edwin Bramall. Heseltine was appointed in January 1983, with the backing of Nott and Party Chairman Cecil Parkinson. Bramall had hoped for a period of consolidation after the reorganisations of the early 1980s and the Falklands War. Thatcher felt that Heseltine was "restless" at the Environment, and that he would bring efficiency reforms to Defence, whilst she also wanted to keep him away from economic and social issues. She appointed her Principal Private Secretary Clive Whitmore as Permanent Under-Secretary for Defence (head civil servant for the department – the job had coincidentally fallen vacant).
Sources: en.wikipedia.org
Delta hexatoxin Hv1 (δ-HXTX-Hv1a, Versutoxin, or Versutotoxin, formerly known as Delta atracotoxin Hv1 and δ-ACTX-Hv1a) is a neurotoxic component found in the venom of the Australian funnel web spider (Atrax robustus). Delta hexatoxin Hv1 can result in fatality for primates, by downregulating the inactivation of voltage gated sodium ion channels (VGSCs) found in motor neurons. The structure of versutoxin contains a central beta region with a cystine knot motif, commonly found in other neurotoxic polypeptides, but not found in sea anemone or alpha-scorpion toxins despite their similar effects in terms of sodium channel modulation.
=== Non-destructive testing === Nuclear magnetic resonance is extremely useful for analyzing samples non-destructively. Radio-frequency magnetic fields easily penetrate many types of matter and anything that is not highly conductive or inherently ferromagnetic. For example, various expensive biological samples, such as nucleic acids, including RNA and DNA, or proteins, can be studied using nuclear magnetic resonance for weeks or months before using destructive biochemical experiments. This also makes nuclear magnetic resonance a good choice for analyzing dangerous samples.
== Books == Anabolic Reference Guide. Mile High Publishing, 1991. Sports Supplement Review. Mile High Publishing, 1997. Body-for-LIFE: 12 Weeks to Mental and Physical Strength. HarperCollins, 1999. ISBN 0-06-019339-5 Body for Life Success Journal. HarperCollins, 2002. ISBN 0-06-051559-7 Eating for Life: Your Guide to Great Health, Fat Loss and Increased Energy! High Point Media, 2003. ISBN 0-9720184-1-7 Transformation: A Path from Physical to Spiritual Well-Being. Hay House, 2010. ISBN 978-1-4019-1176-8
People in ancient East Asia ate tea for centuries, perhaps even millennia, before ever consuming it as a beverage. They would nibble on the leaves raw, add them to soups or greens, or ferment them and chew them as areca nut is chewed. Tea drinking may have begun in the region of Yunnan, where it was used for medicinal purposes. It is believed that in Sichuan, "people began to boil tea leaves for consumption into a concentrated liquid without the addition of other leaves or herbs, thereby using tea as a bitter yet stimulating drink, rather than as a medicinal concoction." Chinese legends attribute the invention of tea to the mythical Shennong (in central and northern China) in 2737 BC, although evidence suggests that tea drinking may have been introduced from southwest China. The earliest written records of tea come from China. The word tú 荼 appears in the Shijing and other ancient texts to signify a kind of "bitter vegetable" (苦菜), and it is possible that it referred to many different plants such as sow thistle, chicory, or smartweed, as well as tea. In the Chronicles of Huayang, it was recorded that the Ba people in Sichuan presented tu to the Zhou king. The Qin later conquered the state of Ba and its neighbour Shu, and according to the 17th-century scholar Gu Yanwu who wrote in Ri Zhi Lu (日知錄): "It was after the Qin had taken Shu that they learned how to drink tea." Another possible early reference to tea is found in a letter written by the Qin dynasty general Liu Kun who requested that some "real tea" to be sent to him.
Sources: en.wikipedia.org
The two share the same 29-amino-acid backbone. CJC-1295 carries an additional albumin-binding moiety that markedly extends its residence time in circulation, while the form without that moiety clears faster. Literature sometimes applies the name loosely to either variant.
It has not been approved by major regulatory agencies for any therapeutic indication. Material sold under this name is typically distributed for laboratory research only. Clinical use is not supported by large controlled trials.
Early human studies of the albumin-binding form reported circulation half-lives on the order of several days. The value depends on assay method and study design. Estimates for the form without the binding moiety are considerably shorter.
It acts on the growth hormone-releasing hormone receptor found on pituitary somatotroph cells. Activation of that receptor triggers growth hormone release through a cyclic AMP dependent pathway.